Read the letter from the Academy's President and Vice President, inviting researchers to contribute to this survey: https://acmedsci.ac.uk/file-download/63879858

Around the world researchers are driving forward research at an unprecedented pace to tackle the COVID-19 pandemic. This project will map the UK landscape of COVID-19 preclinical drug discovery research and development.

We aim to provide a comprehensive overview of research into developing novel therapeutic targets, new molecular entities and repurposing existing medicines.

By contributing to this database, you will support the COVID-19 research effort by enabling the UK research and funding community to quickly identify opportunities for collaboration, avoid duplication of effort and prioritise the most promising research.

We welcome and encourage contributions of a range of types from both academia and industry. We are interested in collating information on two main types of research:

• Preclinical drug discovery and development for COVID-19, covering all modalities, mechanisms of action and therapeutic targets.
• Supporting technologies that will inform and support drug development, including the development of assays, cell models, animal models and specialist reagents.

By submitting a project to the database, you are giving permission for the Academy to publicly display all information that you submit on the COVID-19 preclinical drug development database. You do not need to fill in all available fields if you have concerns around confidentiality or intellectual property. The Academy’s privacy policy, which outlines how submitted data will be handled and stored, can be found at: https://acmedsci.ac.uk/privacy-policy

If you have any questions about the submission process or need to update your submission, please visit the FAQs section for further information or email policy@acmedsci.ac.uk.